Zobrazeno 1 - 10
of 42
pro vyhledávání: '"HÉLIO S. SADER"'
Publikováno v:
Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 39, Iss 1, Pp 27-35 (2003)
Introdução: O teste de suscetibilidade a antimicrobianos representa um dos testes de maior importância clínica realizados pelo laboratório de microbiologia. Devido ao grande número de antimicrobianos e à complexidade dos mecanismos de resistê
Externí odkaz:
https://doaj.org/article/022011f04c354d4a89d8be7d3be9e764
Publikováno v:
Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 38, Iss 1, Pp 13-20 (2002)
O meropenem e o imipenem representam os ß-lactâmicos com maior espectro e potência antimicrobiana, e são os únicos carbapenêmicos disponíveis para uso clínico no Brasil, nos Estados Unidos e na Europa. O meropenem apresenta atividade in vitro
Externí odkaz:
https://doaj.org/article/1833366cb88e40eb97642114334b3a88
Publikováno v:
Emerging Infectious Diseases, Vol 9, Iss 8, Pp 1025-1027 (2003)
Externí odkaz:
https://doaj.org/article/bd78d8d5d9ae4ae8a26787843491e4bc
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 9, Iss 5, Pp 348-356
The in vitro activity of tigecycline (former GAR-936), a new semisynthetic tetracycline, was evaluated in comparison with tetracycline and other antimicrobial agents. MATERIAL AND METHODS: A total of 1,326 contemporary clinical isolates collected fro
Externí odkaz:
https://doaj.org/article/cd4a4e6d360d4d10a9b1978ade90a58e
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 7, Iss 5, Pp 282-289
The accuracy of antimicrobial susceptibility tests is a crucial step for the clinical management of patients with serious infections. They must be reliable and precise because they will guide antimicrobial therapy. Our main objective was to compare t
Externí odkaz:
https://doaj.org/article/b001ebf6aab94700bededc95a32d86fc
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Bloodstream infection (BSI) is associated with poor outcomes especially when effective antimicrobial therapy and control of infection source are delayed. As the frequency of Enterobacterales producing metallo-β-lactamases (MBL) a
Externí odkaz:
https://doaj.org/article/a98da34197b84688bdabda89653527cc
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 11 (2024)
ABSTRACT This study reports the activity of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp. isolates collected from the United States and Europe, including Israel and Turkey, from 2020 to 2021. Among Enterobactera
Externí odkaz:
https://doaj.org/article/765cb9d27be34b02b8cbe9c652e4ce3f
Publikováno v:
Antibiotics, Vol 13, Iss 6, p 564 (2024)
We evaluated the activities of aztreonam/avibactam and recently approved β-lactamase inhibitor combinations (BLICs) to compare the antimicrobial susceptibility patterns of Enterobacterales and Pseudomonas aeruginosa isolated from intensive care unit
Externí odkaz:
https://doaj.org/article/08871ef02f3243d7b65bcb044824b4f6
Publikováno v:
International Journal of Infectious Diseases, Vol 116, Iss , Pp 306-312 (2022)
ABSTRACT: Background: High-dose cefepime-tazobactam (WCK 4282) is currently under clinical development at a dosage of 2 grams/2 grams every 8 hours with prolonged infusion (90 minutes). Objective: To evaluate the in vitro activity of high-dose cefepi
Externí odkaz:
https://doaj.org/article/5081ff46a758456c84fd75e8958c5a56
Autor:
HÉLIO S. SADER, RODRIGO E. MENDES, ANA C. GALES, RONALD N. JONES, MICHAEL A. PFALLER, CASSIA ZOCCOLI, JORGE SAMPAIO
Publikováno v:
Jornal de Pneumologia, Vol 27, Iss 2, Pp 59-67 (2001)
Introdução: Pneumonia hospitalar é a mais fatal das infecções hospitalares, com taxas de mortalidade de 30 a 60%. Estima-se que 15% de todas as mortes associadas à hospitalização estejam diretamente relacionadas a pneumonias hospitalares. O S